# Response to BNT162b2 Vaccine in Adolescents With Type 1 Diabetes

> **NCT05620251** · — · COMPLETED · sponsor: **Istanbul Medeniyet University** · enrollment: 121 (actual)

## Conditions studied

- type1diabetes

## Interventions

- **DIAGNOSTIC_TEST:** Blood test

## Key facts

- **NCT ID:** NCT05620251
- **Lead sponsor:** Istanbul Medeniyet University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-03
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-06-12
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2022-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05620251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05620251, "Response to BNT162b2 Vaccine in Adolescents With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05620251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*